Position in LH
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$4,913,720
+$251,750 QoQ
Shares Held
17,549
+0.4% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#246
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 24%
Shared 14%
None 63%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $750,824,495 across 25 Diagnostics & Research names. LH ranks #12 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,187,054 | $382,526,542 | |
| 2 | DHR |
Danaher Corp /De/
|
705,975 | $134,474,118 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
115,405 | $60,753,808 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
26,295 | $33,592,125 | |
| 5 | A |
Agilent Technologies, Inc.
|
243,555 | $32,351,410 | |
| 6 | ICLR |
Icon PLC
|
114,844 | $19,949,551 | |
| 7 | RVTY |
Revvity, Inc.
|
162,985 | $18,133,711 | |
| 8 | ILMN |
Illumina, Inc.
|
91,197 | $16,035,168 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,913,720 | 17,549 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $4,661,970 | 17,473 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,781,795 | 31,018 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $7,746,887 | 26,987 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,563,011 | 25,001 | Shares | Defined | 2025-09-26 | |
| 2025-03-31 | $5,747,512 | 24,695 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,540,728 | 32,883 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $7,563,009 | 33,842 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $5,577,190 | 27,405 | Shares | Other | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||